SOME PHARMACOLOGIC PROPERTIES OF BENZPHETAMINE HYDROCHLORIDE. 1964

W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING

UI MeSH Term Description Entries
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D010633 Phenmetrazine A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE. Defenmetrazin,Fenmetrazin,Oxazimedrine,Phenmetraline,Phenmetrazine Hydrochloride,Preludin,Hydrochloride, Phenmetrazine
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001067 Appetite Depressants Agents that are used to suppress appetite. Anorectic,Anorectic Agent,Anorectics,Anorexic Drug,Anorexigenic Drug,Appetite Depressant,Appetite Suppressant,Appetite Suppressants,Appetite-Depressing Drug,Appetite-Suppressant Drug,Anorectic Agents,Anorexic Drugs,Anorexigenic Drugs,Appetite-Depressing Drugs,Appetite-Suppressant Drugs,Agent, Anorectic,Agents, Anorectic,Appetite Depressing Drug,Appetite Depressing Drugs,Appetite Suppressant Drug,Appetite Suppressant Drugs,Depressant, Appetite,Depressants, Appetite,Drug, Anorexic,Drug, Anorexigenic,Drug, Appetite-Depressing,Drug, Appetite-Suppressant,Drugs, Anorexic,Drugs, Anorexigenic,Drugs, Appetite-Depressing,Drugs, Appetite-Suppressant,Suppressant, Appetite,Suppressants, Appetite
D001589 Benzphetamine A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222) Benzfetamine,Didrex
D014116 Toxicology The science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations. Toxinology,Evidence Based Toxicology,Evidence-Based Toxicology,Based Toxicologies, Evidence,Based Toxicology, Evidence,Evidence Based Toxicologies,Evidence-Based Toxicologies,Toxicologies, Evidence Based,Toxicologies, Evidence-Based,Toxicology, Evidence Based,Toxicology, Evidence-Based

Related Publications

W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
April 1951, The Journal of pharmacology and experimental therapeutics,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
November 1954, The Journal of pharmacology and experimental therapeutics,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
January 1972, Farmakologiia i toksikologiia,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
October 1965, Archives internationales de pharmacodynamie et de therapie,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
November 1969, Toxicology and applied pharmacology,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
April 1971, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
July 1960, Arizona medicine,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
August 1988, The American journal of cardiology,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
May 1961, Toxicology and applied pharmacology,
W VELDKAMP, and A P TAZELAAR, and W A FREYBURGER, and H H KEASLING
February 1968, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!